Posted Feb. 8, 2013 at 8:55 a.m.

Premium Lock Tranzyme board decides to explore possible sale or merger

Published: 2013-02-08 08:55:00
Updated: 2013-02-08 08:55:00


Drug development firm Tranzyme, its stock trading well under $1, has decided to explore a possible sale, merger or other options that can "maximize value to its stockholders."...

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders